Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Tesla
TSLA
|
+$860M |
| 2 |
Amazon
AMZN
|
+$636M |
| 3 |
Microsoft
MSFT
|
+$586M |
| 4 |
AbbVie
ABBV
|
+$503M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$213M |
Top Sells
| 1 |
Home Depot
HD
|
+$282M |
| 2 |
Chevron
CVX
|
+$273M |
| 3 |
American Tower
AMT
|
+$188M |
| 4 |
ACC
American Campus Communities, Inc.
ACC
|
+$136M |
| 5 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$99.7M |
Sector Composition
| 1 | Technology | 23.66% |
| 2 | Healthcare | 14.93% |
| 3 | Financials | 13.33% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRTA
2801
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$351M
| $3.87M | ﹤0.01% |
960,471
+9,679
| +1% | +$39K |
|
2802
Atomera
ATOM
$106M
| $3.86M | ﹤0.01% |
381,270
+11,246
| +3% | +$114K |
|
2803
Ramaco Resources Class A
METC
$1.6B
| $3.86M | ﹤0.01% |
433,619
+141,741
| +49% | +$1.26M |
|
2804
Tecnoglass
TGLS
$3.32B
| $3.86M | ﹤0.01% |
183,676
-6,920
| -4% | -$145K |
|
2805
Zynex
ZYXI
$44.8M
| $3.86M | ﹤0.01% |
425,114
+5,606
| +1% | +$50.8K |
|
2806
Equinor
EQNR
$61.2B
| $3.85M | ﹤0.01% |
116,214
| – | – |
|
2807
PCB Bancorp
PCB
$308M
| $3.84M | ﹤0.01% |
212,754
+555
| +0.3% | +$10K |
|
2808
Arbutus Biopharma
ABUS
$855M
| $3.84M | ﹤0.01% |
2,009,840
+224,798
| +13% | +$429K |
|
2809
Red River Bancshares
RRBI
$432M
| $3.83M | ﹤0.01% |
77,535
-3,044
| -4% | -$150K |
|
2810
Park Aerospace
PKE
$372M
| $3.83M | ﹤0.01% |
346,875
+955
| +0.3% | +$10.5K |
|
2811
Third Coast Bancshares
TCBX
$549M
| $3.82M | ﹤0.01% |
223,174
+80,705
| +57% | +$1.38M |
|
2812
FVCBankcorp
FVCB
$240M
| $3.81M | ﹤0.01% |
248,430
+580
| +0.2% | +$8.89K |
|
2813
Provident Bancorp
PVBC
$226M
| $3.8M | ﹤0.01% |
265,413
-12,526
| -5% | -$179K |
|
2814
Century Therapeutics
IPSC
$43.3M
| $3.8M | ﹤0.01% |
383,997
+100,705
| +36% | +$996K |
|
|
NPKI
2815
NPK International Inc.
NPKI
$889M
| $3.79M | ﹤0.01% |
1,504,959
-21,139
| -1% | -$53.3K |
|
2816
Rallybio
RLYB
$25.1M
| $3.79M | ﹤0.01% |
261,718
+67,911
| +35% | +$983K |
|
2817
Gannett
GCI
$620M
| $3.79M | ﹤0.01% |
2,473,998
+36,630
| +2% | +$56K |
|
2818
Purple Innovation
PRPL
$114M
| $3.78M | ﹤0.01% |
933,662
-194,376
| -17% | -$787K |
|
2819
ZimVie
ZIMV
$532M
| $3.78M | ﹤0.01% |
382,617
+7,473
| +2% | +$73.8K |
|
2820
Vivid Seats
SEAT
$110M
| $3.77M | ﹤0.01% |
24,630
+683
| +3% | +$105K |
|
2821
Lexicon Pharmaceuticals
LXRX
$418M
| $3.77M | ﹤0.01% |
1,569,022
+227,609
| +17% | +$546K |
|
2822
ALX Oncology
ALXO
$56.8M
| $3.76M | ﹤0.01% |
393,321
+13,121
| +3% | +$126K |
|
2823
Palladyne AI
PDYN
$309M
| $3.76M | ﹤0.01% |
282,098
+67,726
| +32% | +$902K |
|
2824
Inspired Entertainment
INSE
$253M
| $3.75M | ﹤0.01% |
425,044
-4,326
| -1% | -$38.2K |
|
2825
DHI Group
DHX
$141M
| $3.75M | ﹤0.01% |
696,885
-12,549
| -2% | -$67.5K |
|